MYC and acute leukemia: In line with reported outcomes for BET inhibitors JQ1 and I-BET in acute leukemia and other hematologic malignancies [2], [4], OTX015 also decreased c-MYC mRNA or protein as shown in the majority of the cell lines, as well as in primary acute leukemia samples.